Please login to the form below
neurology
This page shows the latest neurology news and features for those working in and with pharma, biotech and healthcare.
Axovant licenses another gene therapy as new strategy beds in
In neurology that includes a number of serious neurodegenerative disorders like Huntington disease.
Latest news
-
Biogen and Eisai claim mid-stage win for Alzheimer’s drug
This is the first late-stage anti-amyloid antibody study to successfully achieve statistically significant results at 18 months, further validating the amyloid hypothesis, ”said Eisai’s head of neurology Lynn
-
Lundbeck signs $1.1bn deal for Prexton and Parkinson’s drug
The Danish drugmaker is already a big player in neurology and psychological diseases, and PD is a core focus for the company which has suffered some pipeline setbacks of late, including
-
Biogen cuts $217m deal for Karyopharm neurology drug
Biogen cuts $217m deal for Karyopharm neurology drug. The biotech hopes to begin phase I trials of KPT-350 by the end of the year.
-
Sanofi licences Principia MS drug in $805m deal
The agreement allows Principia to maximize the BTK opportunity in neurology with a strong partner for PRN2246, while focusing internal resources on our lead BTK inhibitor in another therapeutic area, ”said
-
Alexion's Soliris gets US approval for myasthenia gravis
Alexion's Soliris gets US approval for myasthenia gravis. New neurology indication could contribute $1.2bn to sales, says analysts. ... The new indication represents the first foray for Alexion in neurology and a massive development for MG patients in
More from news
Approximately 8 fully matching, plus 143 partially matching documents found.
Latest Intelligence
-
A quest for innovative solutions
Ecosystem. “I have the most beautiful job in the company because my team and I are exposed to the change externally, ”says Erik Janssen, UCB’s head of innovative solutions, Neurology
-
The good, the bad and the ugly
Biogen was the largest seller in the CNS market in 2017 and this is forecast to continue, ”says Rahael Maladwala, analyst, neurology and ophthalmology, GlobalData. ... Neurology experienced slow growth, largely because few diseases are very well
-
Deal Watch October 2016
$330m. Neurology 2016. Aspen. 5 anesthetics. $770m royalties. $592m. 1.3. Neurology 2014. ... Lilly. AZD3293. $500 profit share. Neurology 2012. Impax US. Zomig US.
-
Deal Watch August 2016
So the product, which is an orphan drug, ended up in the portfolio of a $10bn company focussed on GI, dermatology and neurology and which was under investigation by the SEC
-
Deal Watch October 2015
Over the past few years, Merck KGaA has been realigning its healthcare business to focus on oncology, immuno-oncology, immunology and neurology and so its partnership with BioMarin for treatments for
More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.
Latest appointments
-
Axovant poaches Allergan’s and Teva’s chief medical and science officers
Corcoran’s career history has seen him supervise drug development across multiple therapeutic areas including neurology and psychiatry.
-
Topas Therapeutics appoints chief development officer and chief medical officer
vice president, multiple sclerosis/neurology and immunology.
-
GW Pharmaceuticals strengthens research and development team
Volker has an impressive record of successful new drug development and obtaining regulatory approvals which together with his deep experience in neurology, makes him ideally suited to lead GW’s clinical
-
Sam Agus takes up new role at Hansa Medical
Agus has previously held various leading positions at several pharmaceutical companies includingAbbott Laboratories and most recently at H.Lundbeck A/S as it’s chief specialist, medical affairs neurology. ... With experience in medical strategy,
-
J&J’s clinical research neuroscience director joins MedAvante
He also brings extensive experience in psychiatry, neurology and dermatology, making him an ideal addition to MedAvante's scientific leadership team.”.
More from appointments
Approximately 0 fully matching, plus 30 partially matching documents found.
Latest from PMHub
-
Forecasting in Forgotten Markets
Forecasting in Forgotten Markets. In this article, Anthony Woodhead, Business Development Manager for Black Swan Analysis, discusses the challenges facing innovators in markets like Dementia, which has attracted significant investment over time but
-
Lighthouse Medical Communications US bolster their senior scientific team
number of key therapeutic areas such endocrinology, neurology, oncology, hematology, women’ s health and rare diseases.
-
90TEN boosts PR division with hires from Biosector 2 and Tonic
Patel moves to 90TEN following three years at Tonic Life Communications, where she worked on international accounts spanning oncology, neurology and medical devices.
-
THE OTHER SIDE OF … MULTIPLE SCLEROSIS
And for the past 15 years Robert has been by her side for every visit to the neurology department.
-
Wilmington Healthcare
Christos Begkos, University of Manchester. "Service redesign provided us with development of integrated, person-centred care and greater focus on proactive management of the neurology patients most in need of care.".
More from PMHub
Approximately 1 fully matching, plus 9 partially matching documents found.
Featured jobs
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Business Unit Head, Medical Communications, London
-
Excellent package
-
Client Services Director - Med Comms
-
Great salary and bebefits
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
Subscribe to our email news alerts
- Moving annual total (MAT)
- Brexit rebels win vote on European Medicines Agency alignment
- MaxCyte gets green light for solid tumour cell therapy
- Communiqué Awards 2018: Photo Gallery - Communiqué Awards 2016
- NHS England to Vertex: come clean on Orkambi offer
- AstraZeneca joins Merck in Brexit stockpiling effort
- Random42 win Creativity International Award for Scientific Animation
- Merck & Co joins big pharma pricing pledge – but sceptics unconvinced
- Aurora partners with PIPHealth and taps into patient panels
- FDA’s Gottlieb lambasts industry’s biosimilar-blocking tactics
- Allergan’s abicipar matches AMD blockbuster Lucentis in phase III
- OUTiCO growth in multi-channel creates more job openings
PMHub
Clark Health Communications
Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...
Latest intelligence
- Developing advocacy in the pharmaceutical industry.
- The importance of advocacy programmes...
- GDPR and events. What does the pharma industry need to know?
- Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
Quick links
Infographics
